Makers Laboratories Limited (MAKERSL) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE987A01010
Key metrics
- Market Cap
- ₹115 Cr
- P/E Ratio
- 33.81
- EPS
- 6.1
- Book Value
- 207.57
- P/B Ratio
- 0.94
- ROE
- 1.92%
- ROCE
- 8.14%
- Debt / Equity
- 0.05
- Net Margin
- 1.69%
- Revenue Growth
- 16.24%
- Profit Growth
- -68.61%
- Dividend Yield
- —
- 52W High
- ₹236.55
- 52W Low
- ₹109.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Makers Laboratories Limited
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, antiinflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company also exports its products. Makers Laboratories Limited was incorporated in 1984 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 114
- Promoter Holding
- 68.55%
The full Makers Laboratories Limited analysis
Create a free account to open the complete MAKERSL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.